Cargando…
Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer
Secreted protein acidic and rich in cysteine (SPARC) gene has been shown to be epigenetically silenced in several cancers. We investigated the loss of expression and promoter methylation of this tumor suppressor gene in gastric cancers and correlated the data with clinicopathological features. We ob...
Autores principales: | Chen, Zi-Yi, Zhang, Jun-Ling, Yao, Hong-Xin, Wang, Peng-Yuan, Zhu, Jing, Wang, Wei, Wang, Xin, Wan, Yuan-Lian, Chen, Shan-Wen, Chen, Guo-Wei, Liu, Yu-Cun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268651/ https://www.ncbi.nlm.nih.gov/pubmed/25516351 http://dx.doi.org/10.1038/srep07035 |
Ejemplares similares
-
Secreted Protein Acidic and Rich in Cysteine (SPARC) Suppresses Angiogenesis by Down-Regulating the Expression of VEGF and MMP-7 in Gastric Cancer
por: Zhang, Jun-Ling, et al.
Publicado: (2012) -
Aberrant methylation of SPARC in human lung cancers
por: Suzuki, M, et al.
Publicado: (2005) -
Aberrant methylation of SPARC in human lung cancers
por: Suzuki, M, et al.
Publicado: (2013) -
Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival
por: Yin, Jie, et al.
Publicado: (2010) -
Methylation of the SPARC gene promoter and its clinical implication in pancreatic cancer
por: Gao, Jun, et al.
Publicado: (2010)